These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26818624)
21. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857 [TBL] [Abstract][Full Text] [Related]
22. Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. Maschio M; Albani F; Jandolo B; Zarabla A; Contin M; Dinapoli L; Fabi A; Pace A; Baruzzi A J Neurooncol; 2008 Nov; 90(2):217-21. PubMed ID: 18612799 [TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities. Sugiyama I; Bouillon T; Yamaguchi M; Suzuki H; Hirota T; Fink M Drug Metab Pharmacokinet; 2015 Apr; 30(2):160-7. PubMed ID: 25989891 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS. Chen X; Gu E; Wang S; Zheng X; Chen M; Wang L; Hu G; Cai JP; Zhou H J Chromatogr Sci; 2016 Mar; 54(3):334-42. PubMed ID: 26499119 [TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy. Li X; Wei S; Wu H; Zhang Q; Zhao Z; Mei S; Feng W; Wu Y Eur J Pediatr; 2023 Oct; 182(10):4509-4521. PubMed ID: 37493972 [TBL] [Abstract][Full Text] [Related]
26. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations. Ahmad A; Garnett WR Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654 [TBL] [Abstract][Full Text] [Related]
27. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. Keränen T; Sorri A; Moilanen E; Ylitalo P Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131 [TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children. Rodrigues C; Chiron C; Rey E; Dulac O; Comets E; Pons G; Jullien V Br J Clin Pharmacol; 2017 Dec; 83(12):2695-2708. PubMed ID: 28771787 [TBL] [Abstract][Full Text] [Related]
29. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Vainionpää LK; Mikkonen K; Rättyä J; Knip M; Pakarinen AJ; Myllylä VV; Isojärvi JI Epilepsia; 2004 Mar; 45(3):197-203. PubMed ID: 15009219 [TBL] [Abstract][Full Text] [Related]
30. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children. Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784 [TBL] [Abstract][Full Text] [Related]
31. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Mintzer S; Boppana P; Toguri J; DeSantis A Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614 [TBL] [Abstract][Full Text] [Related]
32. [Oxcarbazepine in the treatment of epilepsy. A review and update]. Horga de la Parte JF; Horga A Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324 [TBL] [Abstract][Full Text] [Related]
33. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326 [TBL] [Abstract][Full Text] [Related]
34. Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy. Yao N; Huang S; Huang A; Song H Eur J Clin Pharmacol; 2022 Oct; 78(10):1667-1675. PubMed ID: 36006433 [TBL] [Abstract][Full Text] [Related]
35. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739 [TBL] [Abstract][Full Text] [Related]
36. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study. Wegner I; Wilhelm AJ; Sander JW; Lindhout D Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050 [TBL] [Abstract][Full Text] [Related]
38. Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state. Cardot JM; Degen P; Flesch G; Menge P; Dieterle W Biopharm Drug Dispos; 1995 Oct; 16(7):603-14. PubMed ID: 8785383 [TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215 [TBL] [Abstract][Full Text] [Related]